Effect of renal impairment on the pharmacokinetics of exenatide

por Linnebjerg, Helle, Kothare, Prajakti A, Park, Soomin, Mace, Kenneth, Reddy, Shobha, Mitchell, Malcolm, Lins, Robert
Publicado 2007

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial

por Kothare, Prajakti A, Seger, Mary E, Northrup, Justin, Mace, Kenneth, Mitchell, Malcolm I, Linnebjerg, Helle
Publicado 2012

An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs

por Kothare, Prajakti A., Bateman, Kevin P., Dockendorf, Marissa, Stone, Julie, Xu, Yang, Woolf, Eric, Shipley, Lisa A.
Publicado 2016

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

por McDonnell, David P, Detke, Holland C, Bergstrom, Richard F, Kothare, Prajakti, Johnson, Jason, Stickelmeyer, Mary, Sanchez-Felix, Manuel V, Sorsaburu, Sebastian, Mitchell, Malcolm I
Publicado 2010

Making Better Dose Decisions: Using Exposure‐Response Modeling to Integrate Efficacy Outcome of Two Phase IIb Clinical Trials of Ubrogepant for Migraine Treatment

por Li, Chi‐Chung, Voss, Tiffini, Kowalski, Ken, Yang, Bei, Kleijn, Huub Jan, Jones, Christopher J., Bosch, Rolien, Michelson, David, DeAngelis, Matthew, Xu, Yang, Xie, Iris, Kothare, Prajakti A.
Publicado 2020

Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study

por Dockendorf, Marissa F., Murthy, Gowri, Bateman, Kevin P., Kothare, Prajakti A., Anderson, Melanie, Xie, Iris, Sachs, Jeffrey R., Burlage, Rubi, Goldman, Andra, Moyer, Matthew, Shah, Jyoti K., Ruba, Rachel, Shipley, Lisa, Harrelson, Jane
Publicado 2018